June 16, 2017

Didanosine 10 mg/mL Oral Suspension

This preparation is a good example of how pharmacists can be involved in managing patients’ therapy.

May 19, 2017

Topiramate 20 mg/mL Oral Suspension

This agent helps reduce seizure activity and prevent migraines by acting on several chemicals in the brain.

April 21, 2017

Erythromycin 1% Topical Gel

The patient should be counseled that the viscosity of this preparation is temperature dependent.

March 17, 2017

Amitriptyline HCl 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% in Transdermal Pain Base

This preparation may be used topically to treat pain.

February 16, 2017

Furosemide 10 mg/mL Oral Suspension

Furosemide is used to treat edema associated with various disorders, as well as adjunctively to treat acute pulmonary edema.

January 19, 2017

Sucralfate 200 mg/mL and Nystatin 20,000 U/mL Oral Suspension

This preparation may be used in the treatment of ulcerations, erosions, and esophageal infections.

December 16, 2016

Famotidine 8 mg/mL Oral Liquid

This formulation may be used to treat heartburn in patients who cannot swallow tablets or take the commercial product.

November 17, 2016

Venlafaxine Hydrochloride 15 mg/mL

The oral suspension formulation has been used in the treatment of major depressive disorder, anxiety, and panic disorder.

October 14, 2016

Bosentan 6.25 mg/mL Oral Suspension

Bosentan is classified as hazardous by NIOSH and should be handled accordingly.

September 16, 2016

Estradiol, Estriol, and Estrone in HRT Cream Base

In addition to its suitability for dermatologic applications, this cream base is an effective vehicle for hormones.